Conference Coverage
Ineffective renal denervation blamed for trial’s failure
Major finding: Renal denervation produced an average 14 mm Hg drop in systolic blood pressure, compared with an average 12 mm Hg decline in...
WASHINGTON – Far from being doomed after the failure SYMPLICITY HTN-3, renal denervation for refractory hypertension will continue to be explored. But it can’t go very far without finding a way to measure its effectiveness.
In Part 2 of our interview, Dr. Prakash Deedwania and Dr. George Bakris explore the options, and don’t miss the chance to talk about the controversial new hypertension guidelines.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.
On Twitter @mitchelzoler
